Results 151 to 160 of about 20,252 (251)
Transoral Ultrasound Diagnosed Bilateral Peritonsillar Abscess in Patient Admitted With Tonsillitis
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Transoral ultrasound is a valuable tool for PTA diagnostics, especially when the diagnosis is uncertain due to ambiguous findings.
Amalie Hartvig Pall Posselt +2 more
wiley +1 more source
Epithelial‐Myoepithelial Carcinoma of Minor Salivary Glands of the Palate: A Systematic Review
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims Epithelial‐myoepithelial carcinoma (EMC) is a very rare malignant neoplasm of the salivary glands. It mainly affects the major salivary glands. Little is known about the specificity of EMC in minor salivary glands (MSGs), which represents a diagnostic challenge. Methods A systematic review was performed to identify clinical
Nour M. Khattab +2 more
wiley +1 more source
Serum Histatin Levels in COVID‐19: Association With Disease Severity and Immune Status
Journal of Medical Virology, Volume 98, Issue 6, June 2026.ABSTRACT Histatins are histidine‐rich antimicrobial peptides with emerging immunomodulatory properties; however, their systemic behavior across the clinical spectrum of COVID‐19 remains unknown. We aimed to characterize serum histatin levels in patients with mild COVID‐19 (without pneumonia) and severe COVID‐19 (with pneumonia) and to explore factors ...
Umut Aydın +3 more
wiley +1 more source
Upper Airway Obstruction due to Kaposi Sarcoma—Presenting Sign of HIV: Case Report and Review
The Laryngoscope, Volume 136, Issue 6, Page 2631-2637, June 2026.This study presents a case of undiagnosed HIV presenting with Kaposi sarcoma (KS) of the head and neck with acute upper airway obstruction (UAO) and provides an updated scoping literature review to examine the patient characteristics, lesion characteristics, interventions, and outcomes of KS cases with UAO from the pharynx, larynx, and/or trachea.
Zachary A. Wykoff +3 more
wiley +1 more source
Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review
The Laryngoscope, Volume 136, Issue 6, Page 2449-2460, June 2026.PRISMA flow diagram indicating the process of systematic inclusion and exclusion of articles. ABSTRACT Objective Mesna (Sodium 2‐mercaptoethanesulfonate) is widely used as a mucolytic agent and uroprotective agent. Recently, its disulfide bond‐breaking property has been applied in otologic surgery to facilitate safer dissection of cholesteatoma and ...
Kevork H. Atamian +4 more
wiley +1 more source
Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario
The Laryngoscope, Volume 136, Issue 6, Page 2598-2604, June 2026.The uptake of MAiD for head and neck cancer (HNC) has been steadily increasing since 2016, when MAiD first became available in Canada. Our study projects a substantial increase in the future use of MAiD for patients with HNC. As such, our health system needs to re‐evaluate and implement the necessary infrastructure to support the projected increase in ...
Tanika Curry +8 more
wiley +1 more source
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.ABSTRACT Objective To identify and compare how patient perceptions contribute to Type 1 Delays, defined as delays in deciding to seek care, among individuals with head and neck cancer (HNC) in high‐income countries (HICs) and low‐ and middle‐income countries (LMICs).
Meredith A. Anderson +10 more
wiley +1 more source
Clinicopathological Characteristics and Postoperative Outcomes Following Parotidectomy: A Ten-Year Retrospective Study from a Tertiary Center. [PDF]
DiseasesAljarba M +5 more
europepmc +1 more source
Medical Physics, Volume 53, Issue 6, June 2026.Abstract Background Sequential boost radiotherapy (RT) poses a challenge in allocating dose across multiple plans while protecting organs at risk (OARs). Clinicians must decide whether OAR sparing should occur primarily in the initial plan, the boost plan(s), or all plans, resulting in a time‐intensive, iterative optimization process.
Austen Matthew Maniscalco +7 more
wiley +1 more source
Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source